Evidence map›Paper›PMID 30510240›Full record

ArticleNature genetics2019

Error-prone bypass of DNA lesions during lagging-strand replication is a common source of germline and cancer mutations.

Vladimir B Seplyarskiy, Evgeny E Akkuratov, Natalia Akkuratova, Maria A Andrianova, Sergey I Nikolaev, Georgii A Bazykin, Igor Adameyko, Shamil R Sunyaev

Abstract read
In one paragraph

Article in Nature genetics, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed
1.8field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed, 49 citations in OpenAlex.

  1. Article
  2. Article
  3. What sets the mutation rate of a cell type in an animal species?bioRxiv : the preprint server for biology · 2025
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Mechanisms of DNA repair and mutagenesis induced by acetaldehyde, acrolein, aristolochic acids, and vinyl chloride.Journal of environmental science and health. Part C, Toxicology and carcinogenesis · 2025
    Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. DNA lesion bypass and the stochastic dynamics of transcription-coupled repair.Proceedings of the National Academy of Sciences of the United States of America · 2024
    Article
  16. Article
  17. Disentangling sources of clock-like mutations in germline and soma.bioRxiv : the preprint server for biology · 2023
    Article
  18. Article
  19. Strand asymmetries across genomic processes.Computational and structural biotechnology journal · 2023
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 5 institutions in 5 countries.

Vladimir B Seplyarskiy *Division of Genetics, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
Evgeny E Akkuratov *Institute of Translational Biomedicine, St. Petersburg State University, St. Petersburg, Russia.
Natalia Akkuratova *Institute of Translational Biomedicine, St. Petersburg State University, St. Petersburg, Russia.
Maria A AndrianovaSkolkovo Institute of Science and Technology, Skolkovo, Russia.
Sergey I NikolaevInserm U981, Gustave Roussy Cancer Campus, Université Paris Saclay, Villejuif, France.
Georgii A BazykinInstitute for Information Transmission Problems (Kharkevich Institute), Russian Academy of Sciences, Moscow, Russia.
Igor AdameykoDepartment of Physiology and Pharmacology, Karolinska Institutet, Stockholm, Sweden.
Shamil R SunyaevDivision of Genetics, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA. ssunyaev@rics.bwh.harvard.edu.ORCID http://orcid.org/0000-0001-5715-5677
Brigham and Women's Hospital · USSkolkovo Institute of Science and Technology · RUSt Petersburg University · RUInserm · FRKarolinska Institutet · SE

Funding

Statistical methods for studies of rare variantsR01MH101244 · NIMH · HARVARD MEDICAL SCHOOL · PI Benjamin Michael Neale, ALKES L PRICE · 2013 to 2026
$9.4M
The origin, the function and the phenotypic impact of human allelesR35GM127131 · NIGMS · HARVARD MEDICAL SCHOOL · PI SHAMIL SUNYAEV · 2018 to 2026
$8.1M
Powering whole genome sequence-based genetic discovery for common human diseases- Extended 2021-2022.U01HG009088 · NHGRI · HARVARD SCHOOL OF PUBLIC HEALTH · PI LIN, XIHONG, NEALE, BENJAMIN MICHAEL · 2016 to 2021
$5.1M
NHGRI NIH HHS U01 HG009088NIGMS NIH HHS R35 GM127131NIMH NIH HHS R01 MH101244
6 · The paper itself

Abstract

Studies in experimental systems have identified a multitude of mutational mechanisms including DNA replication infidelity and DNA damage followed by inefficient repair or replicative bypass. However, the relative contributions of these mechanisms to human germline mutation remain unknown. Here, we show that error-prone damage bypass on the lagging strand plays a major role in human mutagenesis. Transcription-coupled DNA repair removes lesions on the transcribed strand; lesions on the non-transcribed strand are preferentially converted into mutations. In human polymorphism we detect a striking similarity between mutation types predominant on the non-transcribed strand and on the strand lagging during replication. Moreover, damage-induced mutations in cancers accumulate asymmetrically with respect to the direction of replication, suggesting that DNA lesions are resolved asymmetrically. We experimentally demonstrate that replication delay greatly attenuates the mutagenic effect of ultraviolet irradiation, confirming that replication converts DNA damage into mutations. We estimate that at least 10% of human mutations arise due to DNA damage.

Indexed as

Cells, CulturedDNADNA DamageDNA RepairDNA ReplicationGerm-Line MutationHumansMutagenesisNeoplasmsPolymorphism, Single NucleotideTranscription, GeneticDNA

Identifiers

PMID30510240
PMCPMC6317876
OpenAlexW2949226983

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.